You just read:

Frost & Sullivan Commends Sensus for the Development of SRT-100™ and SRT-100 Vision™, its Low-energy Radiation Therapy Systems for Treating Skin Cancer

News provided by

Frost & Sullivan

20 Mar, 2014, 14:52 GMT